Get my own profile
Public access
View all20 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Wyndham WilsonNational Cancer InstituteVerified email at mail.nih.gov
- Elaine JaffeNational Cancer InstituteVerified email at mail.nih.gov
- Louis M. StaudtNational Cancer InstituteVerified email at mail.nih.gov
- rahul lakhotiaStaff Clinician, Lymphoid Malignancies Branch, National Cancer InstituteVerified email at nih.gov
- John A. ButmanNational Institutes of HealthVerified email at nih.gov
- Michele CeribelliStaff Scientist, Division of Pre-Clinical Innovation, NCATS, NIHVerified email at nih.gov
- Jeremy S. AbramsonAssociate Professor of Medicine, Harvard Medical SchoolVerified email at mgh.harvard.edu
- James D PhelanStaff Scientist, National Cancer InstituteVerified email at nih.gov
- Jagan MuppidiNational Institutes of HealthVerified email at nih.gov
- Mark A. Ahlman, MDMedical College of Georgia - Augusta UniversityVerified email at augusta.edu
- Miloš MiljkovićCartesian TherapeuticsVerified email at cartesiantx.com
- Catherine LaiAssociate Professor, University of PennsylvaniaVerified email at pennmedicine.upenn.edu
- Roland SchmitzJustus-Liebig-University, GießenVerified email at patho.med.uni-giessen.de
- Maryalice Stetler-StevensonNational Cancer InstituteVerified email at mail.nih.gov
- Matthias HoldhoffJohns Hopkins UniversityVerified email at jhmi.edu
- Michael GlantzPenn State School of MedicineVerified email at hmc.psu.edu
- William Douglas Figg, SrNational Cancer InstituteVerified email at mail.nih.gov
- Svetlana PackHead, Chromosome Pathology Section, National Cancer InstituteVerified email at mail.nih.gov
- Cody PeerNational Cancer InstituteVerified email at nih.gov
- Manali KamdarAssociate Professor, University of ColoradoVerified email at ucdenver.edu